Hospital-acquired Infections Market Size, Share and Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2024 – 2032
Report ID: GMI4304
Download Free PDF
Authors:
Mariam Faizullabhoy ,
Hospital-acquired Infections Market Size
Hospital-Acquired Infections Market size will expand at a notable pace over 2024-2032, credited to the rise in cosmetic surgeries and increasing social media influence.
The lack of basic hygiene services in healthcare facilities and the growing geriatric population are among the prominent reasons behind the increasing cases of hospital-acquired infections. As per the WHO’s report, between 2015 and 2050, the proportion of the global population aged 60 years or above will nearly double from 12% to 22%. The rate of hospitalization will therefore increase since elder people are susceptible to chronic diseases. Moreover, mounting investment to revitalize and strengthen public health infrastructures will bolster the need for HAI treatment.
Further, the aging population and increasing disposable income among consumers have contributed to the surge in aesthetic-focused practices. As individuals seek to maintain a youthful appearance and improve self-confidence, they are more willing to invest in cosmetic procedures and treatments offered by plastic surgery clinics. Additionally, the growing trend of medical tourism has expanded the reach of plastic surgery clinics, attracting patients from around the world who are seeking high-quality and affordable aesthetic procedures. This may lead to the prevalence of HAI.
Hospital-Acquired Infections Market Trends
There is a rising demand for innovative infection control technologies and products, such as UV disinfection systems, antimicrobial textiles, and advanced air purification systems, to supplement traditional infection control measures and reduce the transmission of pathogens in healthcare settings. This factor, along with regulatory initiatives and healthcare accreditation standards focusing on infection prevention & control are driving healthcare facilities to prioritize HAI reduction efforts and invest in evidence-based interventions. As a result, the HAI market is witnessing a shift towards comprehensive, multidisciplinary approaches to infection prevention, encompassing not only clinical interventions but also environmental, behavioral, and technological solutions.
Hospital-Acquired Infections Market Analysis
Urinary tract infection (UTI) segment is poised to grow substantially till 2032, given the escalating number of elective surgeries across private hospitals. Since catheters are required for bedbound patients after surgical procedures, the prevalence of UTI is projected to grow. Likewise, the high incidence of urinary incontinence among adult women will drive the implementation of hospital-acquired infection control strategies to limit urinary tract infections across healthcare settings.
The antifungal treatment segment is poised to showcase a decent growth trajectory through 2032, driven by the increasing incidence of fungal infections in healthcare settings, the growing population of immunocompromised patients, and the development of novel antifungal therapies. Fungal infections pose a significant risk to patients, particularly those with compromised immune systems or who have undergone invasive medical procedures. Antifungal treatments come handy for combating these fungal pathogens and improving patient outcomes.
Asia Pacific hospital-acquired infections market is set to gain traction over 2024-2032, driven by the rising prevalence of healthcare-associated infections, increasing healthcare spending, and expanding medical infrastructure. Countries like China, India, and Japan are witnessing rapid urbanization, demographic changes, and the emergence of new healthcare challenges, leading to a greater focus on infection prevention and control measures.
Hospital-Acquired Infections Market Share
Some of the key players in the hospital-acquired infections industry are:
These companies are focusing on innovative treatment launches, partnerships, and acquisitions to reinforce their footprint in the global industry.
Hospital-Acquired Infections Industry News
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Security & defense sector journals and trade press
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 30+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →